Milne Jill C. bought BCRX
June 11, 2026 · Form 4 insider transaction
Milne Jill C. bought 33,540 shares of BioCryst Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
33,540
Price
$0.00
Total value
N/A
InsiderMilne Jill C.
RoleOfficer, Director
SecurityAutomatic Stock Option Grant
Transaction codeA: Grant or award
Transaction dateJune 11, 2026
Filing dateJune 15, 2026
Shares owned after33,540
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.